Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
3.340
+0.280 (9.15%)
Mar 9, 2026, 3:37 PM EDT - Market open
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of $402.79 million as of March 9, 2026. Its market cap has increased by 144.11% in one year.
Market Cap
402.79M
Enterprise Value
239.07M
1-Year Change
144.11%
Ranking
Category
Stock Price
$3.34
Market Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has increased from $214.50M to $402.79M, an increase of 87.78%. That is a compound annual growth rate of 6.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 331.50M | 1.66% |
| Dec 31, 2025 | 326.10M | 84.13% |
| Dec 31, 2024 | 177.10M | 138.04% |
| Dec 29, 2023 | 74.40M | -92.92% |
| Dec 30, 2022 | 1.05B | 17.98% |
| Dec 31, 2021 | 890.20M | 220.56% |
| Dec 31, 2020 | 277.70M | 255.12% |
| Dec 31, 2019 | 78.20M | -74.15% |
| Dec 31, 2018 | 302.50M | -60.22% |
| Dec 29, 2017 | 760.40M | 30.72% |
| Dec 30, 2016 | 581.70M | 7.13% |
| Dec 31, 2015 | 543.00M | 153.15% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PepGen | 390.83M |
| Benitec Biopharma | 388.45M |
| Armata Pharmaceuticals | 385.91M |
| Monopar Therapeutics | 384.98M |
| Shattuck Labs | 379.05M |
| Ginkgo Bioworks Holdings | 378.35M |
| LENZ Therapeutics | 365.15M |
| Candel Therapeutics | 361.84M |